0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects.

Kamran Hosseini Subba Rao GollamudiHarvey ReiserThomas R WaltersRichard L Lindstrom

Published in: Clinical ophthalmology (Auckland, N.Z.) (2023)

SURF-201 is an effective topical, preservative-free corticosteroid when dosed BID for the treatment of postoperative inflammation and prevention of pain in a post-cataract population.

Keyphrases

cataract surgery
double blind
open label
placebo controlled
chronic pain
oxidative stress
patients undergoing
pain management
phase iii
clinical trial
neuropathic pain
phase ii
replacement therapy
postoperative pain
smoking cessation